Therapeutic time window for conivaptan treatment against stroke-evoked brain edema and blood-brain barrier disruption in mice

Pathogenesis of Brain Edema and Investigation into Anti-Edema Drugs

(2015) Shotaro Michinaga et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Arginine-Vasopressin Receptor Blocker Conivaptan Reduces Brain Edema and Blood-Brain Barrier Disruption after Experimental Stroke in Mice

(2015) Emil Zeynalov et al.   PLoS One

Treatment of stroke related refractory brain edema using mixed vasopressin antagonism: a case report and review of the literature

(2014) Vishnumurthy Shushrutha Hedna et al.   BMC Neurology

Emergency and Critical Care Management of Acute Ischaemic Stroke

(2014) Stephen A. Figueroa et al.   CNS DRUGS

Vasopressin-Induced Constriction of the Isolated Rat Occipital Artery is Segment Dependent

(2013) Stephen P. Chelko et al.   JOURNAL OF VASCULAR RESEARCH

Hyponatremia and antidiuresis syndrome

(2011) Marie-Christine Vantyghem et al.   ANNALES D ENDOCRINOLOGIE

Vasopressin Amplifies the Production of Proinflammatory Mediators in Traumatic Brain Injury

(2010) Joanna Szmydynger-Chodobska et al.   JOURNAL OF NEUROTRAUMA

Tumour necrosis factor-α affects blood-brain barrier permeability and tight junction-associated occludin in acute liver failure

(2010) Sa Lv et al.   LIVER INTERNATIONAL

Antagonistas del receptor de vasopresina: los vaptanes

(2010) Carles Villabona   Endocrinologia y Nutricion

Low Doses of Carbon Monoxide Protect Against Experimental Focal Brain Ischemia

(2009) Emil Zeynalov et al.   NEUROTOXICITY RESEARCH

The perivascular pool of aquaporin-4 mediates the effect of osmotherapy in postischemic cerebral edema*

(2008) Emil Zeynalov et al.   CRITICAL CARE MEDICINE